MicroRNA-126: a promising novel biomarker in peripheral blood for diabetic retinopathy

Journal Title: International Journal of Ophthalmology - Year 2017, Vol 10, Issue 4

Abstract

"AIM: To investigate the content of serum microRNA-126 (miR-126) and its role in screening retinal endothelial injury and early diagnosis of proliferative diabetic retinopathy. METHODS: The study included 184 serum samples, 59 samples from healthy individuals, 44 samples from diabetes mellitus (DM) patients without diabetic retinopathy (NDR), 42 from non-proliferative diabetic retinopathy (NPDR) patients and 39 samples from proliferative diabetic retinopathy (PDR) patients. The expression of miR-126 was evaluated using a real-time quantitative polymerase chain reaction. RESULTS: The serum content of miR-126 declined as the damage degree in the retina. There was significant difference between the two retinopathy groups (P<0.001). No difference was observed in miR-126 content between healthy individuals and NDR patients (P>0.05). Receiver operating characteristic curve (ROC) analyses indicated that serum miR-126 had significant diagnostic value for PDR. It yielded an area under the curve (AUC) of ROC of 0.976 with 81.21% sensitivity and 90.34% specificity in discriminating PDR from healthy controls, and an AUC of ROC of 0.919 with 84.75% sensitivity and 94.41% specificity in discriminating NDR and NPDR from healthy controls. When the diagnostic threshold was greater than or equal to 8.43, there was an increase in the possibility of NPDR. When the content of miR-126 was less than or equal to 5.02, the possibility of the occurrence of PDR increased. CONCLUSION: Serum miR-126 can serve as a non-invasive biomarker for screening retinal endothelial injury and early diagnosis PDR."

Authors and Affiliations

Mei-Xia An

Keywords

Related Articles

A Chinese family with Axenfeld-Rieger syndrome: report of the clinical and genetic findings

"AIM: To describe a Chinese family affected by a severe form of Axenfeld-Rieger syndrome (ARS) and characterize the molecular defect in PITX2 in the family. METHODS: Patients presented with typical ARS from a Chinese fam...

Clinical and experimental study on angiopoietin-like protein 8 associated with proliferative diabetic retinopathy

"AIM: To confirm the role of angiopoietin-like protein 8 (Angptl 8) in proliferative diabetic retinopathy (PDR). METHODS: The sera and aqueous humor of 10 PDR patients and 10 non-diabetic retinopathy (NDR) patients (idio...

Expressions of nestin and glial fibrillary acidic protein in rat retina after optic nerve transection

"AIM: To assess the expression of nestin and glial fibrillary acidic protein (GFAP) in rat retina after optic nerve transection. METHODS: Rats were randomly divided into normal control group, sham group and operation gro...

Treatment of Coats’ disease: an analysis of pooled results

"AIM: To elucidate the association of treatment modality to vitreoretinal fibrosis and traction retinal detachment (TRD) in Coats’ disease. METHODS: A PubMed search for Coats’ disease with included studies describing eye...

Download PDF file
  • EP ID EP605115
  • DOI 10.18240/ijo.2017.04.05
  • Views 50
  • Downloads 0

How To Cite

Mei-Xia An (2017). MicroRNA-126: a promising novel biomarker in peripheral blood for diabetic retinopathy. International Journal of Ophthalmology, 10(4), -. https://europub.co.uk/articles/-A-605115